Case Report
BibTex RIS Cite

Year 2023, Volume: 14 Issue: 2, 30 - 32, 07.07.2023

Muharrem Çiçek Özlem Kalaycık Şengül Yasin Akkuş Yusuf Ziya Varlı Neval Topal

https://doi.org/10.33706/jemcr.1231222
Cited By: 1

Abstract

Keywords

Acute dystonia metoclopramide multisystem inflammatory syndrome in child

Supporting Institution

yok

Project Number

yok

References

  • Lau Moon Lin M, Robinson PD, Flank J, Sung L, Dupuis LL. The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis. Drug Saf. 2016;39(7):675-87.
  • Dingli K, Morgan R, Leen C. Acute dystonic reaction caused by metoclopramide, versus tetanus. BMJ. 2007;334(7599):899-900.
  • Yis U, Ozdemir D, Duman M, Unal N. Metoclopramide induced dystonia in children: two case reports. Eur J Emerg Med. 2005;12(3):117-9.
  • Kofman AD, Sizemore EK, Detelich JF, Albrecht B, Piantadosi AL. A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report. BMC Infect Dis. 2020;20(1):716.
  • Aldawas A, Ishfaq M. COVID-19: Multisystem Inflammatory Syndrome in Children (MIS-C). Cureus. 2022;14(1):e21064.
  • Çiçek G, Ayaz İO, Ünal I, Önal Ö, Arıcı T, Yücel B, et al. Could COVID‐19 cause loss of spermmotility? Cukurova Med J. 2021;46(2):858-60.
  • Tianyi FL, Agbor VN, Njim T. Metoclopramide induced acute dystonic reaction: a case report. BMC Research Notes. 2017;10(1):32.
  • Lewis K, O'Day CS. Dystonic Reactions. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
  • Boran ÖF, Büyükfırat E, Elibol FE, Dolu H, Dalyan MA, Karadağ S. Biperiden intoksikasyonunda fizostigmin kullanımı: olgu sunumu. KSU Tıp Fak Der. 2016;11(1):20-1.
  • Bentes AA, Dos Santos Junior WR, Pessoa NL, Costa TA, Oliveira GFG, Diniz LMO, et al. Neuro-COVID-19 with or without the multisystem inflammatory syndrome (MIS-C): a single-center study : COVID-19: neurologic manifestations in children. J Mol Neurosci. 2023:1-9.
  • Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607-8.
  • Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094.
  • Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19): The CDC Health Alert Network. 2020 [16.06.2022]. Available from: https://emergency.cdc.gov/han/2020/han00432.asp.
  • Multisystem inflammatory syndrome in children and adolescents with COVID-19 World Health Organization (WHO). 2020; [22.06.2022]. Available from: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.
  • Mahmoud S, El-Kalliny M, Kotby A, El-Ganzoury M, Fouda E, Ibrahim H. Treatment of MIS-C in children and adolescents. Curr Pediatr Rep. 2022;10(1):1-10.

Diagnosis of Multisystem Inflammatory Syndrome in Child (MIS-C) Case Presenting with Acute Dystonia Secondary to Use of Metoclopramide

Year 2023, Volume: 14 Issue: 2, 30 - 32, 07.07.2023

Muharrem Çiçek Özlem Kalaycık Şengül Yasin Akkuş Yusuf Ziya Varlı Neval Topal

https://doi.org/10.33706/jemcr.1231222
Cited By: 1

Abstract

Metoclopramide is a dopamine antagonist in the central nervous system and an antiemetic agent. It can cause extrapyramidal symptoms side effects such as dystonic reactions characterized by involuntary, sustained or spasmodic contractions of muscle groups, resulting in twisting, repetitive or abnormal postures. In this study, we aimed to report a pediatric patient who presented with acute dystonia due to metoclopramide use and was finally diagnosed with MIS-C.

Keywords

Acute dystonia metoclopramide multisystem inflammatory syndrome in child

Project Number

yok

References

  • Lau Moon Lin M, Robinson PD, Flank J, Sung L, Dupuis LL. The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis. Drug Saf. 2016;39(7):675-87.
  • Dingli K, Morgan R, Leen C. Acute dystonic reaction caused by metoclopramide, versus tetanus. BMJ. 2007;334(7599):899-900.
  • Yis U, Ozdemir D, Duman M, Unal N. Metoclopramide induced dystonia in children: two case reports. Eur J Emerg Med. 2005;12(3):117-9.
  • Kofman AD, Sizemore EK, Detelich JF, Albrecht B, Piantadosi AL. A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report. BMC Infect Dis. 2020;20(1):716.
  • Aldawas A, Ishfaq M. COVID-19: Multisystem Inflammatory Syndrome in Children (MIS-C). Cureus. 2022;14(1):e21064.
  • Çiçek G, Ayaz İO, Ünal I, Önal Ö, Arıcı T, Yücel B, et al. Could COVID‐19 cause loss of spermmotility? Cukurova Med J. 2021;46(2):858-60.
  • Tianyi FL, Agbor VN, Njim T. Metoclopramide induced acute dystonic reaction: a case report. BMC Research Notes. 2017;10(1):32.
  • Lewis K, O'Day CS. Dystonic Reactions. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
  • Boran ÖF, Büyükfırat E, Elibol FE, Dolu H, Dalyan MA, Karadağ S. Biperiden intoksikasyonunda fizostigmin kullanımı: olgu sunumu. KSU Tıp Fak Der. 2016;11(1):20-1.
  • Bentes AA, Dos Santos Junior WR, Pessoa NL, Costa TA, Oliveira GFG, Diniz LMO, et al. Neuro-COVID-19 with or without the multisystem inflammatory syndrome (MIS-C): a single-center study : COVID-19: neurologic manifestations in children. J Mol Neurosci. 2023:1-9.
  • Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607-8.
  • Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094.
  • Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19): The CDC Health Alert Network. 2020 [16.06.2022]. Available from: https://emergency.cdc.gov/han/2020/han00432.asp.
  • Multisystem inflammatory syndrome in children and adolescents with COVID-19 World Health Organization (WHO). 2020; [22.06.2022]. Available from: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.
  • Mahmoud S, El-Kalliny M, Kotby A, El-Ganzoury M, Fouda E, Ibrahim H. Treatment of MIS-C in children and adolescents. Curr Pediatr Rep. 2022;10(1):1-10.
There are 15 citations in total.

Details

Primary Language English
Subjects Clinical Sciences
Journal Section Case Report
Authors

Muharrem Çiçek 0000-0002-8619-2722

Özlem Kalaycık Şengül 0000-0001-9594-5231

Yasin Akkuş 0000-0001-9782-7458

Yusuf Ziya Varlı 0000-0001-9648-3796

Neval Topal 0000-0003-2771-8744

Project Number yok
Publication Date July 7, 2023
Submission Date January 15, 2023
Published in Issue Year 2023 Volume: 14 Issue: 2

Cite

APA Çiçek, M., Kalaycık Şengül, Ö., Akkuş, Y., Varlı, Y. Z., et al. (2023). Diagnosis of Multisystem Inflammatory Syndrome in Child (MIS-C) Case Presenting with Acute Dystonia Secondary to Use of Metoclopramide. Journal of Emergency Medicine Case Reports, 14(2), 30-32. https://doi.org/10.33706/jemcr.1231222
AMA Çiçek M, Kalaycık Şengül Ö, Akkuş Y, Varlı YZ, Topal N. Diagnosis of Multisystem Inflammatory Syndrome in Child (MIS-C) Case Presenting with Acute Dystonia Secondary to Use of Metoclopramide. Journal of Emergency Medicine Case Reports. July 2023;14(2):30-32. doi:10.33706/jemcr.1231222
Chicago Çiçek, Muharrem, Özlem Kalaycık Şengül, Yasin Akkuş, Yusuf Ziya Varlı, and Neval Topal. “Diagnosis of Multisystem Inflammatory Syndrome in Child (MIS-C) Case Presenting With Acute Dystonia Secondary to Use of Metoclopramide”. Journal of Emergency Medicine Case Reports 14, no. 2 (July 2023): 30-32. https://doi.org/10.33706/jemcr.1231222.
EndNote Çiçek M, Kalaycık Şengül Ö, Akkuş Y, Varlı YZ, Topal N (July 1, 2023) Diagnosis of Multisystem Inflammatory Syndrome in Child (MIS-C) Case Presenting with Acute Dystonia Secondary to Use of Metoclopramide. Journal of Emergency Medicine Case Reports 14 2 30–32.
IEEE M. Çiçek, Ö. Kalaycık Şengül, Y. Akkuş, Y. Z. Varlı, and N. Topal, “Diagnosis of Multisystem Inflammatory Syndrome in Child (MIS-C) Case Presenting with Acute Dystonia Secondary to Use of Metoclopramide”, Journal of Emergency Medicine Case Reports, vol. 14, no. 2, pp. 30–32, 2023, doi: 10.33706/jemcr.1231222.
ISNAD Çiçek, Muharrem et al. “Diagnosis of Multisystem Inflammatory Syndrome in Child (MIS-C) Case Presenting With Acute Dystonia Secondary to Use of Metoclopramide”. Journal of Emergency Medicine Case Reports 14/2 (July 2023), 30-32. https://doi.org/10.33706/jemcr.1231222.
JAMA Çiçek M, Kalaycık Şengül Ö, Akkuş Y, Varlı YZ, Topal N. Diagnosis of Multisystem Inflammatory Syndrome in Child (MIS-C) Case Presenting with Acute Dystonia Secondary to Use of Metoclopramide. Journal of Emergency Medicine Case Reports. 2023;14:30–32.
MLA Çiçek, Muharrem et al. “Diagnosis of Multisystem Inflammatory Syndrome in Child (MIS-C) Case Presenting With Acute Dystonia Secondary to Use of Metoclopramide”. Journal of Emergency Medicine Case Reports, vol. 14, no. 2, 2023, pp. 30-32, doi:10.33706/jemcr.1231222.
Vancouver Çiçek M, Kalaycık Şengül Ö, Akkuş Y, Varlı YZ, Topal N. Diagnosis of Multisystem Inflammatory Syndrome in Child (MIS-C) Case Presenting with Acute Dystonia Secondary to Use of Metoclopramide. Journal of Emergency Medicine Case Reports. 2023;14(2):30-2.

Cited By

Metoclopramide
Reactions Weekly
https://doi.org/10.1007/s40278-023-45600-8
 Download Cover Image